Blum Holdings (BLMH)
OTHER OTC:BLMH
Top Page
Blum Holdings
(OTC:BLMH)
Select Model
Select Model
Rating:46Neutral
Price Target:
$0.39
▼(-43.19% Downside)
Action:ReiteratedDate:01/08/26
The score is held down primarily by weak financial performance—negative equity/leverage risk and poor operating profitability with negative operating cash flow. Technicals add a mildly bearish bias with the stock trading below key moving averages and negative MACD. Valuation is the main offset (very low P/E), while corporate events provide modest support through debt restructuring and an accretive-looking retail acquisition but still highlight dilution/financing dependence.
Positive Factors
Accretive retail acquisition expands cash-generating footprint
Buying a high-volume, fully licensed Bay Area dispensary adds a durable, income-generating retail asset with an established customer base. This materially diversifies revenue toward recurring retail cash flows and positions the company to benefit from long-term cannabis market normalization and scale.
Negative Factors
Negative equity and high leverage
Negative shareholders' equity and a negative debt-to-equity metric signal a structurally weakened balance sheet. This elevated leverage constrains borrowing capacity, raises solvency risk, and limits strategic flexibility, making it harder to fund growth or absorb shocks without dilutive financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Accretive retail acquisition expands cash-generating footprint
Buying a high-volume, fully licensed Bay Area dispensary adds a durable, income-generating retail asset with an established customer base. This materially diversifies revenue toward recurring retail cash flows and positions the company to benefit from long-term cannabis market normalization and scale.
Read all positive factors
Blum Holdings (BLMH) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$6.56M
Dividend YieldN/A
Average Volume (3M)2.87K
Price to Earnings (P/E)―
Beta (1Y)1.64
Revenue Growth-36.70%
EPS GrowthN/A
CountryUS
Employees38
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)-0.25
Shares Outstanding25,230,686
10 Day Avg. Volume2,994
30 Day Avg. Volume2,867
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.56
Price to Sales (P/S)0.29
P/FCF Ratio-1.76
Enterprise Value/Market Cap1.79
Enterprise Value/Revenue0.86
Enterprise Value/Gross Profit1.87
Enterprise Value/Ebitda0.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Blum Holdings Business Overview & Revenue Model
Company Description
Blum Holdings, Inc. cultivates, manufactures, distributes, and retails medical and adult use cannabis products in California. The company operates through Cannabis Retail and Cannabis Distribution segments. It also manages medical marijuana retail...
How the Company Makes Money
Blum Holdings generates revenue through multiple streams, primarily from rental income derived from its managed properties, including long-term leases and short-term rentals. Additionally, the company profits from the sale of developed properties,...
Blum Holdings Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
25
Negative
Cash Flow
40
Negative
| Breakdown | TTM | Dec 2024 | Mar 2024 | Dec 2022 | Mar 2022 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.62M | 12.99M | 33.23M | 52.02M | 42.12M | 6.16M |
| Gross Profit | 6.29M | 6.21M | 14.00M | 16.90M | 11.02M | 2.64M |
| EBITDA | 15.86M | 22.00M | -2.26M | -171.57M | -30.07M | -1.83M |
| Net Income | 9.88M | 33.10M | -14.13M | -188.93M | -31.27M | -30.12M |
Balance Sheet | ||||||
| Total Assets | 45.08M | 24.82M | 32.07M | 40.51M | 271.82M | 100.29M |
| Cash, Cash Equivalents and Short-Term Investments | 388.00K | 1.04M | 862.00K | 1.20M | 6.70M | 34.26M |
| Total Debt | 8.61M | 4.79M | 37.70M | 49.56M | 79.41M | 23.13M |
| Total Liabilities | 52.35M | 29.56M | 77.77M | 77.05M | 125.34M | 41.16M |
| Stockholders Equity | -7.27M | -6.75M | -45.70M | -36.54M | 142.63M | 54.67M |
Cash Flow | ||||||
| Free Cash Flow | -1.79M | -2.15M | -1.29M | -9.76M | -21.93M | -16.31M |
| Operating Cash Flow | -1.75M | -2.14M | -965.00K | -7.83M | -17.96M | -14.84M |
| Investing Cash Flow | -1.28M | 2.03M | 462.00K | 19.61M | 21.67M | 11.80M |
| Financing Cash Flow | 2.39M | 143.00K | 539.00K | -17.27M | 4.50M | 2.70M |
Blum Holdings Technical Analysis
Neutral
0.69
Price Trends
0.28
Negative
0.45
Negative
0.55
Negative
Market Momentum
-0.02
Negative
53.46
Neutral
68.69
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BLMH, the sentiment is Neutral. The current price of 0.69 is above the 20-day moving average (MA) of 0.20, above the 50-day MA of 0.28, and above the 200-day MA of 0.55, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 53.46 is Neutral, neither overbought nor oversold. The STOCH value of 68.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BLMH.
Blum Holdings Risk Analysis
Blum Holdings disclosed 56 risk factors in its most recent earnings report. Blum Holdings reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Blum Holdings Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | $11.18M | -0.55 | 2994.80% | ― | 5.11% | 19.78% | |
46 Neutral | $6.56M | -0.82 | -140.00% | ― | -36.70% | ― | |
45 Neutral | $39.54M | -3.20 | -118.01% | ― | -90.04% | 44.40% | |
45 Neutral | $7.35M | -10.73 | -40.66% | ― | -1.50% | 80.17% | |
40 Underperform | $2.12M | -0.71 | -93.87% | ― | -0.74% | 81.49% |
* Healthcare Sector Average
BLMH
Blum Holdings
0.26
-0.57
-68.56%
TLPH
Talphera
0.79
0.30
61.22%
SISI
Shineco
0.31
-44.83
-99.32%
YCBD
cbdMD
0.70
-1.52
-68.47%
IMCC
IM Cannabis Corp
0.34
-0.98
-74.17%
BFRI
Biofrontera
0.96
0.15
18.67%
Blum Holdings Corporate Events
Business Operations and StrategyPrivate Placements and Financing
Blüm Holdings Restructures Debt and Issues Equity Securities
Positive
Jan 7, 2026
On December 31, 2025, Blüm Holdings converted approximately $3.05 million of outstanding unsecured debt and accrued interest into 3,248,547 shares of common stock at a fixed price of $0.98 per share, a move that removed a significant portion ...
Business Operations and StrategyM&A Transactions
Blüm Holdings Expands Bay Area Cannabis Retail Footprint
Positive
Dec 18, 2025
On December 18, 2025, Blüm Holdings, Inc. closed the acquisition of all outstanding equity of a high-volume, fully licensed cannabis retail dispensary in a major Bay Area market, expanding its Northern California footprint. The acquired store...
Business Operations and StrategyPrivate Placements and Financing
Blum Holdings Secures $1.5M Through Promissory Notes
Positive
Dec 5, 2025
Blum Holdings, Inc. executed several unsecured promissory notes totaling $1.5 million with a related accredited investor, each bearing an 8% annual interest rate and maturing between September and November 2027. These notes, issued in early Decemb...
Business Operations and StrategyFinancial DisclosuresM&A TransactionsPrivate Placements and Financing
Blum Holdings Issues Shares for Debt Repayment
Positive
Nov 14, 2025
On November 13, 2025, Blum Holdings issued shares of its common stock to various parties, including Adnant, LLC, vendors, and shareholders of acquired companies, as part of debt repayments and acquisition agreements. This strategic move is part of...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.